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The human gut microbiome has increasingly been associated with autism spectrum
disorder (ASD), which is a neurological developmental disorder, characterized by
impairments to social interaction. The ability of the gut microbiota to signal across the gutbrain-microbiota axis with metabolites, including short-chain fatty acids, impacts brain
health and has been identified to play a role in the gastrointestinal and developmental
symptoms affecting autistic children. The fecal microbiome of older children with ASD has
repeatedly shown particular shifts in the bacterial and fungal microbial community, which
are significantly different from age-matched neurotypical controls, but it is still unclear
whether these characteristic shifts are detectable before diagnosis. Early microbial
colonization patterns can have long-lasting effects on human health, and pre-emptive
intervention may be an important mediator to more severe autism. In this study, we
characterized both the microbiome and short-chain fatty acid concentrations of fecal
samples from young children between 21 and 40 months who were showing early
behavioral signs of ASD. The fungal richness and acetic acid concentrations were
observed to be higher with increasing autism severity, and the abundance of several
bacterial taxa also changed due to the severity of ASD. Bacterial diversity and SCFA
concentrations were also associated with stool form, and some bacterial families were
found with differential abundance according to stool firmness. An exploratory analysis
of the microbiome associated with pre-emptive treatment also showed significant
differences at multiple taxonomic levels. These differences may impact the microbial
signaling across the gut-brain-microbiota axis and the neurological development of
the children.
Keywords: microbiome, gut-brain-microbiota axis, autism spectrum disorder, short-chain fatty acid, stool form

INTRODUCTION
Autism spectrum disorder (ASD) is a complex, chronic, neurological developmental disorder that
is characterized by impairments to social interaction, as well as repetitive stereotyped behaviors
(Fakhoury, 2015). Among children and adolescents, this disorder affects ∼1 in every 58 to 166
children and is 4 times more prevalent in males than females (Iglesias–Vázquez et al., 2020).
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gut-brain-microbiota axis (de Angelis et al., 2015), it has been
proposed that the gut microbiota plays a role in both the GI- and
developmental symptoms that affect autistic children (de Angelis
et al., 2015; Cryan et al., 2020).
An exciting prospect of the causal role the microbiome may
play in the development and severity of autism is that the
microbiome is modifiable (Halmos et al., 2015; Pham et al., 2021).
A temporary reduction in symptom severity has been observed
after modulation of the gut microbiome using either antibiotic
(Sandler et al., 2000) or fecal microbiome transplantation (Kang
et al., 2017). Probiotics have also been shown to improve stool
consistency and behavioral scores of autistic children (Parracho
et al., 2010). If autism can be detected earlier, behavioral and
dietary interventions can be implemented earlier, and would
potentially be more effective. While the fecal microbiome of
adolescent and older children with ASD has repeatedly shown
shifts to the bacterial and fungal microbial community, it is still
unclear whether these characteristic shifts might be detectable
earlier. In a recent systematic review on the gut microbiota
of children with autism, only 4 of 18 investigations included
children at 2 years of age (Iglesias–Vázquez et al., 2020). In
this study, we analyzed stool samples from young children
who took part in a larger study that compared two preemptive intervention treatments (Whitehouse et al., 2021). The
present work aimed to characterize the gut microbiome and
SCFA concentrations in young children who were showing
behaviors in the first year of life that are associated with a later
autism diagnosis (ASD-risk behaviors). The relationship between
the microbiome composition and function and its association
with clinical measures for autism and neurodevelopment was
investigated. We have also explored the microbiome for any
association with the pre-emptive intervention that these young
children were receiving, which may inform larger studies in
the future.

Autism and its severity are diagnosed by assessing the core
behavioral symptoms using several different diagnostic tools,
which have been reviewed elsewhere (Falkmer et al., 2013).
Children with ASD show high comorbidity of gastrointestinal
(GI) disturbance, which may be linked with neurological
symptom severity (Chaidez et al., 2015), and infants who would
be diagnosed with ASD are also more likely to have experienced
GI symptoms, including constipation and food intolerance
between 6 – 18 months of age (Bresnahan et al., 2015). Children
with autism are also often self-restricting when it comes to dietary
preferences (Hyman et al., 2020); and diet is known to be an
important factor in driving the composition of the microbiome
in both autistic (Yap et al., 2021) and healthy individuals (Xu
and Knight, 2015; Heiman and Greenway, 2016; Beaumont et al.,
2017).
The gut microbiome is a complex and critical community
(Dave et al., 2012), which has been well-described (in terms of
the bacterial residents) for healthy children and adults (Gilbert
et al., 2018), and significant differences in the composition of the
fecal microbiome between children with autism and neurotypical
children have also been shown (Kang et al., 2013; de Angelis et al.,
2015). It is also now widely recognized that early-life colonization
patterns can have long-lasting effects on human health (Mesa
et al., 2020) and that microbes play a crucial role in maintaining
the normal functioning of their host (Gilbert et al., 2018). This
is achieved in part by the production of exclusive microbial
metabolites, including short-chain fatty acids (SCFA), which,
like the microbial members, are found in dynamic quantities
in the gut. The gut ecosystem will fluctuate in response to diet
and nutrient availability, the presence of antimicrobials, which
affects patterns of cross-feeding (Ríos-Covián et al., 2016), as
well as physical activity, and hygiene practices (Levy et al., 2017).
Lifestyle choices can, therefore, result in shifts or impairments
to the composition of the microbial community, and deficits in
digestion, absorption, or metabolic imbalances can also feed into
GI disturbance and exacerbate a breakdown of the microbial
community. Under such conditions, which favor the growth of
opportunistic pathogenic bacteria, certain microbial products in
the gut can induce an enhanced pro-inflammatory response,
which can compromise the integrity of the gut epithelial barrier
(Martin et al., 2018).
Some bacteria-derived toxins can enter the bloodstream
through leaky gastrointestinal barriers and then pass through
the blood-brain barrier (BBB). These toxins include enterotoxins
and lipopolysaccharides (Lukiw, 2020), and phenols, such as
3-hydroxyphenyl acetic acid (Velásquez-Jiménez et al., 2021),
whereas SCFA plays a part in regulating the BBB (Parker et al.,
2020). These events, which begin in the gut, can have far-reaching
effects due to bidirectional communication, which takes place
within the gut-brain-microbiota axis and involves signaling in
neural, endocrine, and immune systems (Martin et al., 2018).
The microbiome can be affected by modifications to gut motility,
permeability, and intestinal secretions, which are directed by
the brain (Martin et al., 2018), and there is evidence for the
microbiome to play a role in both the development and longterm functioning of the brain (Sharon et al., 2016). Due to
the potential disruption of normal brain development via the
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METHODS
Study Design and Sample Collection
Samples were collected from young children who were enrolled
in a broader study (Whitehouse et al., 2021), which was approved
by the Child and Adolescent Health Service (HREC Ref:
2016008EP) in Perth, Western Australia. This mentioned study
recruited infants between 9 and 14 months who were showing
early social-communication delays as determined by Social
Attention and Communication Surveillance–Revised (SACS-R)
12-month checklist. In this randomized control trial (RCT),
the infants were randomized to one of two intervention arms:
1) iBASIS-VIPP – a parent-mediated video-aided intervention
supporting parent-child interaction, or 2) usual community care
(UCC) – which was varied and was comprised of services
recommended by local health professionals, or included those
with no additional treatment (Whitehouse et al., 2021). As
part of this larger study, autism symptom severity and general
development of the children was assessed at the time of stool
sample collection using both the Mullens Scale of Early Learning
(MSEL) (Mullen, 1995) and the Autism Diagnostic Observation
Schedule, second edition (ADOS-2) (Lord et al., 2012) diagnostic
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2009). DNA was extracted from fecal samples immediately
after homogenization using the QIAamp PowerFecal Pro DNA
kit (QIAGEN, Hilden, Germany) using the IRT protocol
for QIAcube (QIAGEN), according to the manufacturer’s
instructions with three modifications: (1) before adding stool
sample, three 3.5-mm glass beads (Biospec) were added to beadbeating tubes, (2) after step 1, tubes were vortexed for ∼20 s
to incorporate beads and stool, and (3) followed by heating
at 65◦ C for 10 min. Extraction controls were also processed
following the same protocol as frozen stool samples. Fecal
samples for SCFA analysis were frozen at −80◦ C immediately
after homogenization, and then transferred on dry ice to the
Science Analytical Facility at Edith Cowan University, Western
Australia for SCFA quantification as previously described (Jones
et al., 2021).

TABLE 1 | Enrolment, follow-up time points, and behavioral testing that took
place in the AICES RCT.
AICES study
timepoints

Enrollment

Follow up 1

Follow up 2

Follow up 3

Age (months)

33–38

9–14

15–20

21–28

ADOS-2 scoring

x

x

x

MSEL scoring

x

x

Current study
timepoints
number of single
stool samples
received

3

15

number of
replicate stool
samples received

6

6

Boys: Girls

x

x

Timepoint A

Timepoint B

8:1

15:6

Bacterial and Fungal Library Preparation
and Sequencing

The number of stool samples received from this RTC and used in this current fecal
microbiome study is also indicated. Six children provided stool samples at both timepoints
A and B.

Bacterial DNA and gut microbiome mock community (https://
www.atcc.org/products/msa-1006) were amplified using 16S
primers 515F (Turner et al., 1999) and 806R (Caporaso et al.,
2011), while fungal DNA was amplified using ITS2 primers FSeq
and RSeq (Heisel et al., 2015), each with a 6–8 bp unique barcode.
The PCR reactions, library preparation, and sequencing were
performed according to methods previously described (Jones
et al., 2021).

tools (Table 1). ADOS-2 total scores were converted to calibrated
severity scores (CSS), which range from 1 to 10 points (Shumway
et al., 2012). The CSS scale were from scores 6–10 moderateto-severe concern/autism classification, 4–5 mild-to-moderate
concern/autism spectrum classification, and 1–3 little-to-no
concern/non-spectrum classification.
Stool samples were collected as part of the formerly mentioned
study in Perth. Parents were instructed to collect a stool sample
from a nappy or from a plastic lining that covered the toilet,
and, preferably, free of urine, in a sterile screw-top container.
The stool samples were placed inside a sealable bag and frozen
immediately in the household freezer. A provided freezer bag
was used to transport the sample to the clinical assessment site
(CliniKids, SUBIACO/Perth Children’s Hospital, NEDLANDS)
where they were frozen at −80◦ C until transferred to Curtin
University on dry ice. A total of 30 stool samples were collected
from 24 children at two time points during the RCT. Nine
samples were collected 1 year after the study baseline when
the children were between 21 and 28 months of age, and 21
samples were collected 2 years post-baseline when children were
between 33 and 40 months of age. Six of the 24 children provided
stool samples at both one- and two-years post-baseline (Table 1).
Those stool samples were used in this current fecal microbiome
study, for which approval was granted by Human Research Ethics
Committee (approval number HRE2020-0127) from Curtin
University, Western Australia, and all research was conducted in
accordance with the relevant regulations and guidelines.

Deconvolution and Data Quality Filtering
Sequences were demultiplex using unique molecular barcodes
with no mismatches allowed before they were removed along
with primer sequences using Cutadapt (Martin, 2011). Quality
filtering using DADA2 (Callahan et al., 2016) was performed as
previously described (Jones et al., 2021). The Genome Taxonomy
reference database (Version 202) was formatted for use with
DADA2 (https://zenodo.org/record/4735821#.YN18Om4RWis),
and the UNITE general FASTA release for fungi Version 8.3
(Kõljalg et al., 2005) were used to classify 16S and ITS2
sequence variants, respectively, each with a minimum of 80%
bootstrap. Species were then assigned to 16S sequences with
100% identity using the same reference database. The bacterial
and fungal species assignments for the top 50 ASVs were
confirmed by BLAST using the same two databases, at 100%
identity. ASVs with up to three matches were annotated to
include all three potential species assignments, whereas any ASV
with more than three identical matches was annotated with the
genus name followed by “spp.” Identical matches to species’
ID numbers were not included. If taxa are not fully resolved
to a lower rank, the lowest available rank name and sp., gen.,
or fam. have been annotated for each lower taxonomic level.
The package microDecon (McKnight et al., 2019) was used to
remove contamination from all sample sequences with one run
of the function remove.count. Lastly, any ASVs with unassigned
phylum, or with low prevalence (1 read in 5% of samples for
bacterial ASVs and 1 read in 2.5% of fungal sample ASVs) were
filtered out, as were fungal samples (1 sample) with <1,000 reads.
Performing decontamination in conjunction with filtering has

Fecal DNA Extraction and Short-Chain
Fatty Acid Quantification
Fecal material was thawed at 4◦ C and homogenized manually
for 1 min before sample collection for SCFA quantification (1 g
±0.1), and microbial sequencing (0.25 g ±0.05). The Bristol
Stool Form Scale (BSFS) was used to categorize each stool form
during homogenization (Mínguez Pérez and Benages Martínez,
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CSS groups were visualized in Primer using PCoA of BrayCurtis similarity and using PCA in STAMP (Parks et al.,
2014). Significant differences between individual pathways were
also assessed in STAMP using two-sided Welch’s test and the
Benjamini-Hochberg FDR for multiple testing.

been recommended (Cao et al., 2021), and, therefore, these nonaggressive filtering and decontamination thresholds were chosen
to balance noise reduction associated with sparse reads while
retaining less abundant but potentially important species.

Statistical Analysis
To characterize the difference between autistic and non-spectrum
children using CSS, the children were placed into the category
defined by their scores: CSS from 6 to 10 ASD, CSS from 4
to 5 non-autism autism spectrum disorder (NAASD), and CSS
from 1 to 3 no developmental concern (NDC). Also, because
stool form has previously been shown to be associated with alpha
diversity and SCFA concentrations, the samples were placed into
three groups determined by the Bristol stool form scale. Stool
scoring of 1–2 was considered firm, 3–4 was considered normal,
and 5–6 was considered loose. No stools were scored as 7 in
this study. Beta diversity was used to assess differences between
CSS and intervention groups, and stool form using Euclidian
distances of center log-ratio transformed counts and visualized
using Principal coordinates analysis (PCoA). PERMANOVA
was performed in PRIMER-e v7 (Anderson et al., 2008) with
9,999 unrestricted permutations of the raw data and type 3
sum of squares. ANOVA was used to determine differences
in SCFA concentration between CSS groups using the Tukey’s
multiple comparison method to adjust p values. For all SCFA
concentrations, Q-Q plots were used to assume normality, and
Levene’s test was used to check for homogeneity of variance. The
total SCFA concentration was summed from all acids, with the
concentration of valeric acid set to 0 for 3 individuals, where the
concentration was below detection.
Differential abundance testing between CSS groups at the
ASV level was performed in DESeq2 (Love et al., 2014). At the
family, genus, and species level, differences observed between the
intervention group and CSS, were determined using the MannWhitney U test and Bristol stool groups using the Kruskal-Wallis
test (all comparisons included only samples from timepoint
B). The higher-order comparisons were performed only on
dominant reads, which were those with a sum greater than
200 reads across all bacterial samples (372 ASV), and greater
than 25 reads across all fungal samples (136 ASVs). The false
discovery rate (FDR) due to multiple testing was corrected
with a Benjamini-Hochburg adjustment (BH) (Benjamini and
Hochberg, 1995). The core bacteriome consisting of species
with a 20% prevalence and a relative abundance of over 0.01%
were also determined in MicrobiomeAnalyst (Dhariwal et al.,
2017). Pearson correlation was calculated for the linear regression
between MSEL and alpha diversity estimates for bacterial ASV
counts, with normality assumed by the Shapiro-Wilk normality
test. A single sample was removed from this correlation analysis
as no MSEL score was recorded for that sample.
Predictive functional profiling was inferred from the total
bacterial 16S rRNA gene sequence data using Tax4Fun
(Wemheuer et al., 2020). Here, SILVA reference sequences
were mapped to KEGG orthologs (KO), and the profile was
then filtered to include only a core group (>0.01% across all
samples) of metabolic pathways, with photosynthesis (ko00195)
also removed. Differences in the core metabolic profile between

Frontiers in Microbiology | www.frontiersin.org

RESULTS
Description of the Total Bacterial and
Fungal Datasets
The bacteriomes from all children in this study were dominated
by Firmicutes (62%), Bacteroidota (25%), Actinobacteriota
(10%), and the mycobiome was dominated by Saccharomyces
(92%) and Kazachatania (4%). A description of the data
quality, including read depth (Supplementary Table 1), replicate
sampling, and positive control in the form of a bacterial mock
community (Supplementary Figure 1), is summarized in the
supplementary results section.

Microbiome Composition Assessed by
Stool Form and Intervention Group
To explore the data, principal coordinates analysis (PCoA)
was used to visualize beta diversity between stool form, age,
and dominant taxa from stool samples at both time points,
while differences between intervention groups were assessed
only from those samples taken at time point B. A significant
difference in the beta diversity of intervention groups was
determined by PERMANOVA at the level of species (p =
0.014) genus (p = 0.008), family (p = 0.006), and order (p
= 0.008) (Supplementary Figure 2). A significant difference
in the dispersion of Phyla around the centroid between the
two intervention groups was also determined by PERMDISP
(p = 0.04). The difference in community composition seemed
to be driven by a higher abundance of Lachnospirales (p =
0.005, FDR = 0.12) in the iBASIS-VIPP intervention group.
Moreover, 2 families, 8 genera, and 13 species were also
differentially abundant between the two intervention groups
(Supplementary Table 2).
The age in months did not have a clear impact on sample
beta diversity (Supplementary Figure 3), and, independent
of timepoint, bacterial communities clustered according to
stool form (Figure 1A), with firmer stool samples clustering
separately from loose stool samples. Bacterial families with
differential abundance according to stool form were detected
(Supplementary Figure 4). Prior to FDR correction, the
abundance of Butyricicoccaceae and Pasteurellaceae was
significantly higher in loose stool, compared to firm stool (p
> 0.05 FDR > 0.60); the abundance of Enterobacteriaceae was
significantly higher in loose stool compared to normal stool
(p = 0.03 FDR = 0.42); and the abundance of Monoglobales
A UBA1381 was significantly lower in firm stool compared to
normal or loose stool (p = 0.02, FDR = 0.42). A further six
genera were identified to have lower abundance in firm stool
compared to lose or normal stool (p < 0.05, FDR < 0.59), and 3
genera had lower abundance in normal stool compared to a firm
or loose stool (p < 0.03, FDR0.44) (Supplementary Table 3).
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FIGURE 1 | Beta diversity of bacterial (A) and fungal (B) communities from all individuals at both time points using PCoA. (A) Distribution of the bacterial communities
is shown due to stool form and timepoint. (B) Fungal communities are displayed based on dominant taxa and timepoint with abundant ASVs plotted as vectors. Beta
diversity was estimated from Euclidian distances between CLR transformed counts.

Fungal communities, on the other hand, did not group according
to stool form but clustered according to the dominant ASVs
(Figure 1B).

ASVs were enriched in autistic children, half of which belonged
to Lachnospiraceae, and ten bacterial ASVs were significantly
enriched in the NDC group. Two different fungal ASVs were
significantly enriched in both the mycobiome of NDC and
children with autism. Differences in the abundance of genera
and species between CSS groups were also determined. After
correcting for multiple testing (FDR), there were no significant
differences; however, before FDR, there were several taxa
identified (Supplementary Table 4).

Comparison of Microbiome Diversity
Between Diagnosis Outcomes
The microbiome composition among CSS groups was compared
at timepoint B only and showed that the proportions of bacterial
phyla were similar among children with autism and children
in the NDC group. However, the abundance of Actinobacteria
in the NAASD group was considerably lower than in the
other groups (Table 2). Strong interpersonal differences were
observed between all children, and no significant differences were
determined between CSS groups (p > 0.3). Similar alpha diversity
was observed between CSS groups for both bacterial and fungal
communities, and alpha diversity also showed no significant
relationship with MSEL (Figure 2).
Differential abundance testing was used to compare the
microbiome composition at the ASV level among CSS groups
at time point B only. In total, 19 bacterial and 4 fungal
ASVs were detected with significantly different abundance after
adjusting for multiple testing. These ASVs were identified
by the lowest taxonomic rank available (Table 3), and most
bacteria were classified as either Bacteroidia (Bacteroidales) or
Clostridia, most of which were Lachnospiraceae, while most
fungal taxa were classified as Saccharomycetales. Six bacterial

Frontiers in Microbiology | www.frontiersin.org

Temporal Changes in Fecal Samples From
Six Individuals
Six children provided samples at both time point A and timepoint
B. When the 12 samples were clustered using Euclidian distances
(Figure 3), the samples were grouped based on participants,
with a larger difference between one individual. This individual
and one other additional individual each received a different
ADOS-2 score based on their behavior at timepoint B than they
had previously received at timepoint A. Overall the richness,
diversity, and phylogenetic diversity were observed to be higher
at the second time point when the children were on average
36 months of age. The SCFA concentrations did not shift in a
particular direction between time points (Figure 3).
The common core bacteriome between all children at time
points A and B was identified using prevalence and abundance
filtering. A total of 46 species were identified as core members
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TABLE 2 | Description of child and microbiome characteristics at time points A and B, and per diagnosis category.
Time A (n = 9)

mean Age

Boys: Girls

Average stool form

Average MSEL

Act (%)

Bac (%)

Firm (%)

Pro (%)

ASD

25.5

NDC

24.2

3:1

2

74.8

2.9

29.2

66.9

0.5

5:0

3.8

108

2.5

30.3

64.5

0.9

ASD
NAASD

36.4

8:3

3.1

78.7

15.3

17.5

65.6

0.3

36.6

4:1

4.2

97.0

4.0

39.6

53.6

0.2

NDC*a

34.6

3:2

4.0

104.8

10.3

26.9

60.2

1.3

NDC*b

34.8

3:1

4.5

98.3

CSS

Time B (n = 21)
CSS

A single sample was removed from the fungal data, but not the bacterial data, and, therefore, the group characteristics for NDC are different for bacterial *a and fungal *b datasets.
Abbreviated phyla names are Act, Actinobacteriota; Bac, Bacteroidota; Firm, Firmicutes; Pro, Proteobacteria, while abbreviated CSS groups are ASD, Autism, NAASD, non-autistic
autism spectrum disorder, NSD, developmental disorder.

at time point A and 50 at time point B, with 39 of those species
present in both core communities. Blautia A sp, Lachnospiraceae
sp, and Ruminococcaceae sp remained highly prevalent between
both time points, and 50 other species changed only marginally
or not at all between timepoints. Eleven species that were
present in the core microbiome at timepoint B were missing
from the core at time point A, most of which were from
Lachnospiraceae. Phocaeicola sp lost prevalence over time and
Blautia A faecis, Romboutsia timonensis/ilealis, Ruminococcus C
callidus, Clostridia sp, Dialisteraceae sp, and Faecalibacterium sp
all increased in prevalence over time (Figure 4).

CSS groups using PCA (Figure 6), although a significant
difference in the proportion of Tetracycline biosynthesis
(after FDR correction), and several other pathways (before
correction) was identified between CSS groups using Welch’s
t-test (Supplementary Table 5). Differences in the metabolic
profile between intervention groups were also observed
using PCA (Supplementary Figure 5), as well as individual
metabolic pathways.

SCFA Concentrations

Identifying the behaviors associated with autism at a young age
is possible, although predicting the trajectory of young children
who are diagnosed with autism is typically not possible (Hyman
et al., 2020). Roughly 80% of children who are diagnosed at
<3 years of age will retain their diagnosis. However, because
it is difficult to distinguish between either autism, or Pervasive
Developmental Disorder-Not Otherwise Specified a conclusive
diagnosis is difficult to make (Akshoomoff, 2006). Therefore,
in this study, we used CSS and MSEL scores as indicators
of autism symptom severity to explore the gut microbiome
and SCFA associated with these young children. It is also
important to note that the children in the no-developmentalconcern group may not be considered neurotypical controls,
as all children in this study were showing early behavioral
signs of ASD determined by SACS-R at 9 – 14 months
of age.

DISCUSSION

The average, total fecal SCFA concentration across all children
was 119.01 µmol/g (95% CI 104.29–133.73) and the average
molar ratio of acetate, propionate, and butyrate was 67:19:20. No
significant differences in total or individual SCFA concentration
were found between CSS (Figure 2C); however, children in the
ASD group tended to have higher acetic acid, and total SCFA
concentrations, and similarly, total and acetic acid concentrations
negatively correlated with MSEL score (Figure 2E). The SCFA
concentrations were also similar between the two treatment
groups. When relating SCFA concentrations to stool form,
the average concentration of acetate, propionate and the total
SCFA concentration were all highest in normal stool samples,
compared to a firm or loose stool samples, whereas iso-butyrate
and iso-valerate were highest in firm stools, followed by normal
and then loose stools. Butyric acid was the only acid that
increased in concentration with stool looseness (Figure 5).

Overall Composition of the Fecal
Microbiome and SCFA Concentrations
Among CSS Groups

Functional Analysis
Predictive community functional profiling using Tax4fun
returned 321 functional pathways within Cellular Processes,
Environmental Information Processing, Genetic Information
Processing, human diseases, Metabolism, and Organismal
Systems. On average 38.5% of ASVs and 52.7% of sequences per
sample were mapped to a reference KO and used for prediction.
After filtering to include only core metabolic functions, the
profile consisted of 157 pathways within 13 classes. There
was no visual clustering in the core metabolic profile between

Frontiers in Microbiology | www.frontiersin.org

Assessment of the bacteriome about autism has led to conflicting
results, especially when comparing Bacteroidetes and Firmicutes
(Iglesias–Vázquez et al., 2020); although ASD seems to be more
often associated with a decrease in Firmicutes (Andreo-Martínez
et al., 2021). In this study, there was no significant difference
in the relative abundance of any phyla between children with
ASD and NDC, and firmicutes were the most abundant and
prevalent phyla, averaging 62% of the total proportion of reads
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FIGURE 2 | Differences in alpha diversity and SCFA concentration in young children according to autism severity. (A) Fungal community alpha diversity estimates
according to CSS groups. (B) Bacterial community alpha diversity estimates according to CSS groups. (C) Total and individual SCFA concentration (log10) in CSS
groups. (D) Association between MSEL score and bacterial alpha diversity based on Pearson correlation. (E) Association between MSEL score and SCFA
concentration based on Pearson correlation.

can promote the proliferation of anaerobic bacteria (Kovtun
et al., 2020).
Significant differences in both the community composition
(Strati et al., 2017; Coretti et al., 2018; Pulikkan et al., 2018;
Ma et al., 2019) and SCFA concentration (Adams et al., 2011;
Wang et al., 2012; Coretti et al., 2018; Bojović et al., 2020) have
also been observed between autistic and neurotypical controls.
Changes in composition are likely to affect the functional
microbiome and may help reveal the mechanisms, by which the

across all children sampled. The abundance of Actinobacteriota
dropped below 4% of the total community composition in
the NAASD group, and a reduction in this phyla has also
been observed previously in autistic children compared to
neurotypical controls (Coretti et al., 2018). The NAASD group
also had the highest levels of butyrate and propionate in the
study and had a significantly elevated proportion of tetracycline
biosynthesis based on predictive profiling. Tetracyclines are the
most commonly used oral, broad-spectrum antibiotics, which
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TABLE 3 | Bacterial and fungal ASV’s identified with DESeq2 as having significant changes in abundance between CSS groups.
ASD compared to NDC group
ASV# and lowest rank

NAASD compared to NDC group
log2 fold change

Bacteroidaceae
287

Bacteroides
Parasutterella
CHKCI001

6.7

Bacteroides finegoldii

5.3

Christensenellales sp

15.6

14

Debaryomyces hansenii

28.0

127

Ruminococcus A faecicola

24.0

Lactobacillaceae sp

19.7

Oscillospiraceae sp

21.3

Veillonella parvula A

24.1

Bacteroides finegoldii

−24.6

Lactobacillaceae
−22.2

Christensenellales fam
285

Erysipelatoclostridium sp

Lachnospiraceae

Bacteroidaceae
172

194
Debaryomycetaceae

Lachnospiraceae
77

log2 fold change

Erysipelatoclostridiaceae
22.4

Burkholderiaceae
184

ASV# and lowest rank

202
Oscillospiraceae

−20.7

Lachnospiraceae

268
Veillonellaceae

220

Blautia sp

−24.1

211

162

Blautia sp

−22.3

Bacteroidaceae

58

Lachnospiraceae sp

−7.5

172

150

Lachnospiraceae sp

−23.8

Lachnospiraceae
220

Blautia sp

−15.8

162

Blautia sp

−17.6

Saccharomycetaceae
21

Saccharomyces sp

−22.1

13

Eremothecium sinecaudum

−20.3

58

Lachnospiraceae sp

−6.9

150

Lachnospiraceae sp

−23.1

Saccharomyces sp

−19.6

Saccharomycetaceae
21
Positive fold changes are enriched in NDC, and negative fold changes are enriched in ASD or NAASD groups.

FIGURE 3 | Changes in the gut microbiome of 6 children between an average of 24 months of age (timepoint A), and 36 months of age (timepoint B). (A) PCoA of
bacterial beta-diversity based on Euclidian distances of CLR transformed counts and the trajectory of the microbiome across time is shown with a uniquely colored
arrow for each individual. (B) Alpha diversity estimates between timepoint A and B. (C) SCFA concentrations between timepoint A and B.

(Coretti et al., 2018). Considering children with a similar fiber
intake, propionate has again been found in significantly higher
concentrations in the stool of children with autism compared
to neurotypical controls (Wang et al., 2012). This is particularly
important because both acids can cross the BBB and can interact

microbial community may differ due to the ASD phenotype.
SCFA concentrations in stool are good indicators of what was
produced by resident bacteria as they reflect what was excreted
after absorption by the host. Butyrate and propionate are elevated
in stool samples from children with ASD compared to controls
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FIGURE 4 | Shifts in the core microbiome of 6 children between timepoints. (A) Children between 21 and 28 months of age at time points A and (B) children between
33 and 40-months of age at time point B.

in either beta diversity or SCFA concentration between CSS
groups. Instead, butyrate was the only SCFA that increased with
stool looseness. The similar levels of SCFA across CSS groups,
but not Bristol stool groups, may indicate that stool form may
be a confounding factor that makes it difficult to determine
differences between neurological development, especially with
small sample size. It may be that, at this young age, differences in
the community structure associated with neurological disorders
are less pronounced, but still present at a finer scale.
The average richness and diversity of the bacterial community
also increased from the first (A) to second (B) time point
in the six children that provided stool samples at both time
points as did the number of bacterial species included in the
core microbiome. As the diversity of a child’s diet expands
in early life, the microbiome also continues to develop and
increase in diversity (Matamoros et al., 2013). Although, there
was no significant difference in alpha diversity between CSS
groups, and this is consistent with other studies with a larger
number of young participants who were assessed for autism
using various methods (Strati et al., 2017; Pulikkan et al., 2018;
Kong et al., 2019; Fouquier et al., 2021). In this study, there
was a trend for increased bacterial diversity within the NAASD
group, as well as a trend toward a negative correlation between
bacterial diversity and MSEL score. This negative correlation is in
agreement with another study, which found three alpha diversity
measures of the fecal microbiome at 1-year of age that were
negatively correlated with both the Early learning Composite (a
combination of 4 of the 5 standardized T-scores from the MSEL)

FIGURE 5 | Average total and individual SCFA concentrations across Bristol
stool form groups. The Y-axis is plotted on a log2 scale.

with brain cells via G-protein-coupled receptors (Abdelli et al.,
2019). Although, in this study, we found no such difference
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that can cross the BBB (Góra et al., 2018), commonly
found in both higher abundance (Iglesias–Vázquez et al.,
2020), and numbers were based on CFU/g (Finegold et al.,
2017) in fecal samples from children with autism compared
to controls.
Bacteroides caccae has been associated with a decrease in
abundance in the fecal microbiome of children with autism
(Averina et al., 2020) but was enriched in the ASD group in
this study. Certain strains of B. caccae are mucolytic, which may
place them in close proximity to the host, where they can both
influence and be influenced by the host (Tailford et al., 2015).
Furthermore, myocytic bacteria may be opportunistic pathogens
(Ganesh et al., 2013), and because complete degradation of
mucins may require co-metabolism evolving several species
(Tailford et al., 2015), shifts in an abundance of some members
could impact the functionality of the total myocytic community,
which, in turn, would be either beneficial or harmful to the
host. While this finding adds to the catalog of autism-associated
bacterial taxa, it may also indicate the importance of identifying
different bacterial strains, as well as using complementary
metabolite data to fully understand community changes between
groups. Furthermore, the inconsistency seen in the literature
regarding taxa associated with autism may be caused by
differences in databases used for classification. This can be
improved by a multi-omics study design, but also by collecting
information that can influence microbiome composition, such
as diet including fiber and protein content, as well as preor probiotic supplements, GI problems, and information on
bowel movements.

and two of the five Mullen scales at 2-years of age (Carlson et al.,
2018).
While these trends in alpha diversity may indicate new
avenues for future investigation, we caution that it may be
difficult to use traditional diversity indices to describe changes
in the gut that are linked with less understood, heterogeneous,
and modern diseases, such as ASD. Not to mention that the
sequencing depth – the basis on which the diversity measures
are calculated – varies considerably between studies, which
may make it difficult to compare conclusions from different
datasets (Willis, 2019). The inconsistency in alpha diversity
about autism has also been mentioned in a review in this area
(Krajmalnik-Brown et al., 2015). Here we propose that either an
increase or decrease away from the diversity needed to maintain
a healthy homeostatic microbiome may be disadvantageous.
For example, an increase in diversity may indicate a bloom
in pathobionts (Levy et al., 2017), or an increase in usually
more transient bacteria, which may break down the normal
community structure. Similarly, reduced diversity could indicate
a loss of functionality of important microbial members and a
community that is disordered (Levy et al., 2017).

Species and Strain Differences in the Fecal
Microbiome Between CSS Groups
To detect bacteria associated with ASD, we compared differential
abundance between CSS groups. Using the BH adjustment to
control for false positives, we did not detect any significant
features, although, our investigation lacks statistical power using
nonparametric tests with a small sample size, therefore,
we discuss significant results prior to FDR correction.
Overall members of Enterobacteriaceae and Negativicutes
were increased only in the NDC group. Negativicutes are
known for their contribution to propionate production
(Reichardt et al., 2014) and Veillonella (Negativicutes) are
known to ferment lactate to produce SCFA (Kang et al.,
2013). Veillonella are reduced in the fecal microbiome of
children with autism compared to neurotypical controls
(Strati et al., 2017); whereas Enterobacteriaceae have been
found to increase (De Angelis et al., 2013). Lachnospiraceae,
including Muricomes, CHKCI001, and Ruminococcus, were also
enriched in the NDC group compared to either the ASD or
NAASD groups.
Taxa enriched in both non-neurotypical groups included
members of Lachnospiraceae, including Blautia and an
unresolved Lachnospiraceae species. Blautia is bile-metabolizing
and associated with tryptophan metabolism, and has been
found at the reduced abundance in a BTBR T+ Itpr3tf /J
mouse model of ASD (Golubeva et al., 2017). This result is
somewhat contradictory as Blautia are commonly associated
with a typically developing infant microbiome (Hill et al.,
2017), a healthy adult microbiome (Tap et al., 2009), and are
well-known for their contribution to SCFA production (Louis
and Flint, 2017). Clostridium p. was also more abundant in
the ASD group, which is in line with other studies (Gondalia
et al., 2012; Coretti et al., 2018; Ma et al., 2019). Clostridium is
one group of bacteria known to be able to produce toxins

Frontiers in Microbiology | www.frontiersin.org

Stool Form May Help Explain
Inconsistencies in the Bacteriome of
Children With ASD
Poor stool form is an indication of GI distress, and issues,
such as constipation, diarrhea, and flatulence, are reported as
more prevalent in children with ASD than in children with
neurotypical development (Chaidez et al., 2015). The way GI
symptoms are documented could result in variation; for example,
if study participants assess their stool using the Bristol Stool
Scale, there may be individual bias, or error if recalling stool
form after the collection has happened. In this study, stool
form was assessed during sample processing, which allowed
for a non-bias assessment. We found differences in bacterial
composition between firmer stools compared to normal or
loose stools. This finding is in agreement with another study
comparing autistic and neurotypical controls (including sibling
controls), where stool consistency was among the factors most
strongly associated with the microbiome composition (Yap et al.,
2021). However, Yap and colleagues proposed a top-down impact
on stool composition beginning with reduced dietary diversity
due to self-restricting eating habits, and subsequently reduced
microbiome diversity resulting in loose stool consistency.
In our study, both richness and diversity were lower in
firmer stool samples compared to normal or loose stool (data
not shown). Stool becomes firm with lower water content,
and has been linked to longer whole gut transit times (Saad
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FIGURE 6 | Differences in metabolic pathways between CSS groups. (A) Proportion of the predicted pathway tetracycline biosynthesis among CSS groups tested
using Welch’s t-test after FDR correction. (B) PCA distribution of predicted core metabolic pathways by CSS group. The * symbol indicates the significant difference
after FDR correction p = 0.012.

within the intervention group. Using full siblings residing in the
same household as the healthy control group is the most reliable
control group as it covers both environmental factors and genetic
background; however, this would also not be possible with this
pre-emptive study design. We would also like to point out that
there are numerous methods used to diagnose autism severity,
and, therefore, within the literature we discuss several diagnostic
tools have been used. Lastly, due to the small sample size, we
chose to display results that were significant prior to correction
for multiple testing. While this less stringent approach may lead
to more false positives, it may also indicate those taxa that could
be important in the shifts taking place in these young children
that otherwise would be missed.

et al., 2010), which may impose selective pressures on the
microbial community, particularly if the firm stool is experienced
frequently. This same trend in reduced microbial diversity in firm
stool has been observed in adults with functional constipation
(Huang et al., 2018). In our study SCFA concentrations (except
for butyric acid) were also reduced in looser stools, which is
likely due to both water content, and the potential for microbial
members to influence and be influenced by gut motility (Zhao
and Yu, 2016). Therefore, our results are in line with the emerging
hypothesis that the microbiome is part of a circular feedback
loop, where behavior and environment have a top-down effect
on the microbiome and stool form, and the microbiome imposes
a bottom-up effect. Collecting GI disturbance metadata, as well
as recording stool form (as this may change even within a day)
and using this information as a potential confounding variable
might help explain some of the observed inconsistencies in ASDassociated bacteria.

Conclusion and Future Research
In this study, the relative abundance of the microbiome at
the phylum level, and the diversity of bacterial and fungal
communities were similar when viewed among neurological
developmental groups. The microbiome composition and SCFA
concentrations were, instead, found to be significantly associated
with stool form, indicating that this factor might be important
to consider when interpreting the microbiome composition of
young children with autism – especially considering the high
prevalence of gastrointestinal issues in children with ASD. While
bacterial or fungal diversity could not be used to discriminate
between neurological development, differential abundance in the
community structure at the genus, species, and strain level was
detected between CSS groups. Together, these findings indicate
that subtle changes in the bacterial composition may occur in

Limitations
The number of children in this study was limited and the
number of children in diagnostic and treatment groups was
small and unbalanced, and no information regarding diet and
gastrointestinal distress was collected. Also, because the children
were first recruited prior to diagnosis, it was not possible to
choose the number of children in each category. As a result, the
number of children with no developmental concerns were quite
small. Additionally, the diagnosis of the children in the iBASISVIPP and UCC groups were mixed, and due to the sample size,
it was not possible to examine differences between diagnoses
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the microbiome of young children with autism. We also found
that the amount of inter-individual difference in the microbiome
from the 6 children over two time points, did not seem to
be consistent, or related to autism severity. This is likely due
to the small number of samples, but it would be beneficial to
collect a longitudinal series of samples along with diet and bowel
movement history to establish the influence of these factors on
the development of young children showing early behavioral
signs of ASD.
Lastly, pre-emptive treatment for children at risk of
developing autism is an important research area as there
is currently no cure for autism, and treatments that begin
before diagnosis – earlier in life – may be more effective
than those started later in life. The children in this study
were involved in a broader study examining the efficacy of
behavioral interventions for children showing early signs of
ASD (Whitehouse et al., 2021). Although neither behavioral
intervention arm involved dietary changes, and the sample size
was very small, significant differences in bacterial community
structure were observed between the intervention groups. While
it is unclear how the behavioral intervention could impact the
structure of the microbiome, the differences observed at multiple
taxonomic levels between the two treatment groups may indicate
an effect on the microbiome that warrants future research
addressing the possibility of a top-down effect of cognitive
or behavioral changes, which selectively benefit some bacterial
groups. However, this potential needs to be investigated in a
much larger study to account for the many factors affecting the
gut microbiome in the developing child.
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